e-learning
resources
Milan 2017
Monday, 11.09.2017
Functional genomics knowledge in parenchymal and bronchial diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
LSC - 2017 - The role of the epigenetic regulator HMGN5 in COPD resulting from chronic lung injury
J. Dorer (Neuherberg, München, Germany)
Source:
International Congress 2017 – Functional genomics knowledge in parenchymal and bronchial diseases
Session:
Functional genomics knowledge in parenchymal and bronchial diseases
Session type:
Oral Presentation
Number:
2905
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Dorer (Neuherberg, München, Germany). LSC - 2017 - The role of the epigenetic regulator HMGN5 in COPD resulting from chronic lung injury. 2905
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Related content which might interest you:
The role of the epigenetic regulator HMGN5 in COPD resulting from chronic lung injury
Source: ERS Lung Science Conference 2017
Year: 2017
LSC - 2019 - Unraveling the role of miR-223-3p in the regulation of airway inflammation in asthma and COPD
Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of COPD
Year: 2019
The role of chronic inflammation in mouse lung tumourigenesis
Source: Annual Congress 2005 - Pathophysiology of lung cancer progression: impact in diagnosis and early detection
Year: 2005
LSC - 2020 - The role of the COPD susceptibility gene FAM13A in barrier function and pro-inflammatory responses of human airway epithelial cells
Source: Virtual Congress 2020 – Inflammatory pathways in chronic airway diseases
Year: 2020
A role for WNT-5B in airway remodeling in COPD by activation of TGF-beta/Smad3 signaling?
Source: Annual Congress 2013 –COPD: experimental biology
Year: 2013
A potential role for extracellular matrix proteins in lung ageing in COPD
Source: International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease
Year: 2016
Unraveling the role of miR-223-3p in the regulation of airway inflammation in asthma
Source: International Congress 2018 – Understanding the immunopathology that underlies airway obstructive diseases
Year: 2018
The role of the frizzled-8 receptor in COPD with chronic mucus hypersecretion
Source: Annual Congress 2013 –Translational studies in chronic repair and remodelling in the lung
Year: 2013
LSC - 2021 - The role of the systemic inflammation in bronchiectasis exacerbation frequency
Source: Virtual Congress 2021 – Management of chronic cough and obstructive diseases
Year: 2021
Sputum cell mRNA transcripts demonstrate alteration of endothelin metabolism in severe asthma and COPD
Source: Annual Congress 2013 –New drugs in respiratory medicine
Year: 2013
Alterations of the soluble proteome of airway epithelial cells in COPD
Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome)
Year: 2013
IL-17A is elevated in patients with COPD and contributes to airway remodeling by acting on fibroblasts
Source: International Congress 2016 – What's new in biomarker analysis?
Year: 2016
The key role of microRNA-34a in the reduction of sirtuin-1 in COPD
Source: International Congress 2016 – Emerging concepts in lung disease pathogenesis
Year: 2016
Myeloid derived suppressor cell-like fibrocytes are increased and associated with preserved lung function in COPD
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016
YI01 - Follistatin-like 1: a crucial factor in lung development and a novel regulator of airway remodelling
Source: Lung Science Conference 2012 - Rebuilding a diseased lung: Repair and regeneration
Year: 2012
LSC - 2019 - Post-transcriptional dysregulation as a novel mechanism underlying non-responsive severe asthma
Source: International Congress 2019 – Identification of new targets and therapeutic strategies for lung disease
Year: 2019
T cell exhaustion marker expression in the human lung in health and COPD in response to influenza infection
Source: Annual Congress 2013 –COPD and infections
Year: 2013
Expression of vascular remodeling markers in relation to bradykinin receptors in asthma and COPD
Source: Annual Congress 2013 –Emerging new targets for the treatment of respiratory diseases
Year: 2013
Cellular mechanisms underlying CCSP SNP association with chronic airway diseases
Source: International Congress 2015 – New models for treating airway diseases
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept